By Joyce Tait
Successful and sustainable businesses in the Regenerative Medicine industry need to incorporate strategies to address key factors beyond individual business boundaries. These include legal, ethical and financial frameworks, distribution and logistics, and end users willingness to adopt and ability to pay. Business models need to be well adapted to the needs of this market and wil vary depending on whether the end product is a cellular therapy, a delivery system for cells, genes or small molecules or enabling tools and technologies for stimulating endogenous repair. The value systems for each of these types of products are likely to have unique features but will also need to be compliant with global regulatory and legal frameworks.
